SEC Form 4
CareDx, Inc. (CDNA) insider trading
In the 12 months to Oct 26, 2026, 7 CDNA insiders reported open-market sales of $13.3M across 19 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $13.3M
- 19 filings · 7 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 12 of 19
- $9.7M of $13.3M sold (73%)
Who traded CDNA, and when
- Sale
- Sale, pre-arranged (10b5-1)
CDNA daily close from Oct 27, 2025 to Oct 26, 2026, between $14.28 and $70.74, last $68.76. 19 sale and 0 purchase filings by 7 insiders, marked at their filing dates. John Walter Hanna JR., President and CEO: sold $7.5M across 8 filings, first filed Jan 20, 2026, last Jul 17, 2026. Michael Goldberg, Director: sold $2.1M across 1 filing, first filed Aug 6, 2026, last Aug 6, 2026. Hannah Valantine, Director: sold $1.3M across 2 filings, first filed Jun 16, 2026, last Jul 17, 2026. George Bickerstaff, Director: sold $925.7K across 1 filing, first filed Aug 6, 2026, last Aug 6, 2026. Christine Cournoyer, Director: sold $751.0K across 1 filing, first filed Aug 6, 2026, last Aug 6, 2026. Jeffrey Adam Novack, Secretary and General Counsel: sold $452.7K across 5 filings, first filed Nov 10, 2025, last Aug 6, 2026. Arthur A. Torres, Director: sold $214.7K across 1 filing, first filed May 18, 2026, last May 18, 2026.
Largest mark · tap a row for others
John Walter Hanna JR. · President and CEO
Sale $4,458,637
118,000 shares at $37.79 avg
Filed Jul 17, 2026 · traded Jul 16
Pre-arranged (10b5-1) · close on filing date $39.73
John Walter Hanna JR. · President and CEO
President and CEO
$7.5M soldMichael Goldberg · Director
Director
$2.1M soldHannah Valantine · Director
Director
$1.3M soldGeorge Bickerstaff · Director
Director
$925.7K soldChristine Cournoyer · Director
Director
$751.0K soldJeffrey Adam Novack · Secretary and General Counsel
Secretary and General Counsel
$452.7K soldArthur A. Torres · Director
Director
$214.7K soldOpen-market trades
19 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| John Walter Hanna JR. | President and CEO | $7.5M | — | 8 | 100% of sales | |
| Michael Goldberg | Director | $2.1M | — | 1 | — | |
| Hannah Valantine | Director | $1.3M | — | 2 | 100% of sales | |
| George Bickerstaff | Director | $925.7K | — | 1 | — | |
| Christine Cournoyer | Director | $751.0K | — | 1 | 100% of sales | |
| Jeffrey Adam Novack | Secretary and General Counsel | $452.7K | — | 5 | 27% of sales | |
| Arthur A. Torres | Director | $214.7K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Christine Cournoyer Director | SalePre-arranged (10b5-1) | 16,000 | $46.94 | $751.0K | 42,943 | |
traded | George Bickerstaff Director | Sale | 20,000 | $46.29 | $925.7K | 134,061 | |
traded | Michael Goldberg Director | Sale | 44,700 | $47.06 | $2.1M | 61,738 | |
traded | Jeffrey Adam Novack Secretary and General Counsel | SalePre-arranged (10b5-1) | 2,688 | $46.26 | $124.3K | 106,075 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 118,000 | $37.79 | $4.5M | 653,448 | |
traded | Hannah Valantine Director | SalePre-arranged (10b5-1) | 28,779 | $36.15 | $1.0M | 36,686 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 40,000 | $29.24 | $1.2M | 661,959 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 17,683 | $24.03 | $424.9K | 631,959 | |
traded | Hannah Valantine Director | SalePre-arranged (10b5-1) | 12,103 | $23.11 | $279.7K | 36,686 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 21,998 | $24.02 | $528.4K | 649,642 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 4,835 | $24.00 | $116.0K | 671,640 | |
traded | Arthur A. Torres Director | Sale | 10,570 | $20.31 | $214.7K | 38,665 | |
traded | Jeffrey Adam Novack Secretary and General Counsel | Sale | 2,688 | $20.68 | $55.6K | 113,924 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 10,282 | $21.12 | $217.2K | 676,475 | |
traded | Jeffrey Adam Novack Secretary and General Counsel | Sale | 4,441 | $20.56 | $91.3K | 125,364 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 19,480 | $21.16 | $412.2K | 597,405 | |
traded | John Walter Hanna JR. President and CEO | SalePre-arranged (10b5-1) | 10,156 | $21.05 | $213.8K | 616,885 | |
traded | Jeffrey Adam Novack Secretary and General Counsel | Sale | 7,293 | $19.17 | $139.8K | 97,925 | |
traded | Jeffrey Adam Novack Secretary and General Counsel | Sale | 2,688 | $15.52 | $41.7K | 105,218 |
GET /stocks/filings/vX/form-4?tickers=CDNA&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CDNA"
],
"issuer_cik": "0001217234",
"owner_cik": "0001366412",
"accession_number": "0001366412-26-000007",
"form_type": "4",
"filing_date": "2026-08-06",
"period_of_report": "2026-08-04",
"issuer_name": "CareDx, Inc.",
"issuer_trading_symbol": "CDNA",
"owner_name": "Goldberg Michael",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-04",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 44700,
"transaction_price_per_share": 47.0581,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 61738,
"transaction_value": 2103497.0700000003,
"direct_or_indirect": "D"
},
{
"tickers": [
"CDNA"
],
"issuer_cik": "0001217234",
"owner_cik": "0001180466",
"accession_number": "0001180466-26-000008",
"form_type": "4",
"filing_date": "2026-08-06",
"period_of_report": "2026-08-04",
"issuer_name": "CareDx, Inc.",
"issuer_trading_symbol": "CDNA",
"owner_name": "COURNOYER CHRISTINE",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-08-04",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 16000,
"transaction_price_per_share": 46.9358,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 42943,
"transaction_value": 750972.8,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.25 to $47.2250 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 61 records
- Option exercises12 records
- Tax withholding27 records
- Grants and awards22 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has CareDx, Inc.'s CEO sold stock?
Yes. John Walter Hanna JR. (CEO) sold 242,434 shares ($7.5M) between Jan 2026 and Jul 2026, all under a pre-arranged 10b5-1 plan.
How current is CDNA’s insider data?
These are CDNA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track CDNA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CDNA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.